Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLD: Odevixibat in Children With Biliary Atresia Post-Kasai
2024-512086-14-00Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 19
01
Overview
Phase 3, randomised, double-blind trial in biliary atresia comparing Odevixibat with Placebo (2 arms). Primary endpoint: Time from randomization to liver transplant or death. Started Jul 2024; status: completed.
02
Drugs
odevixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on 2024-512086-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512086-14-00.